The medical device system, dubbed VHT-200, is designed to deliver a unique combination of ultrasonic mist and concentrated oxygen to heal chronic wounds and meets a significant unmet medical need in diabetic foot ulcers
Advanced Wound Care In Your Practice. (Credit: Vaporox, Inc.)
US-based medical device company Vaporox has received the US Food and Drug Administration approval for its next-generation healing system to treat chronic wounds.
The medical device system, dubbed VHT-200, is designed to heal chronic wounds, wounds that do not respond to traditional treatment.
The VHT-200 system delivers a unique combination of ultrasonic mist and concentrated oxygen, which have been shown to advance healing.
Vaporox said that its Vaporous Hyperoxia Therapy (VHT) technology has been clinically validated and is a safe and effective adjunct treatment for healing skin wounds.
Its patented, FDA-approved delivery system promotes revascularisation and tissue growth, and addresses a significant unmet medical need in diabetic foot ulcers, said the company.
Vaporox medical director Dustin Kruse said: “Overseeing the clinical study was eye-opening. We consistently observed incredible healing in 20 weeks or less, even on the most complex patients, with the only variable being the addition of VHT.”
According to the medical device company, the VHT-200 system brings advanced wound care technology into the private practice setting.
The system delivers more than 80% healing rates for chronic wounds and enables providers to deliver Advanced Wound Care in their practice.
According to three separate clinical studies, VHT in combination with standard wound care is found to improve healing by two or three folds and deliver results within 20 weeks or less.
Vaporox intends to immediately offer its VHT-200 devices to private practices in the US.
Vaporox Board of Directors chairman Louis Woodhill said: “It has been profoundly satisfying to have played a role in bringing this lifesaving and life-changing technology to market. The VHT-200 represents a major step forward toward a world where all wounds heal.”